Watermark

BGB-dinutuximab beta-101

Completed

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-dinutuximab beta-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20221154

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 12 Months / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 12 Months / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan